AI-Driven CTA Reconstruction for Intracranial LVO

Launched by SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE'S HOSPITAL · Oct 15, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new artificial intelligence (AI) tool designed to improve the treatment of acute ischemic stroke, which occurs when a large blood vessel in the brain is blocked. The goal is to see if this AI can help doctors see the blocked area more clearly on imaging tests called CT angiograms (CTA). By better visualizing the blockage, doctors hope to perform a procedure called endovascular thrombectomy (EVT) more effectively and quickly, which can reduce the damage caused by the stroke.

To participate in this trial, you need to be at least 18 years old and show symptoms of an acute ischemic stroke. You'll undergo some imaging tests, and if doctors find a significant blockage in your brain's blood vessels and determine you are eligible for treatment, you may be invited to join the study. Throughout the trial, you'll receive standard care according to current guidelines, and the researchers will monitor how well the AI tool helps improve your treatment outcomes. It's an exciting opportunity to help advance stroke care while receiving necessary medical attention.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Male or Female, 18 years of age or older.
• • 2. Patients who present with signs and/or symptoms concerning acute ischemic stroke.
• • 3. Patients who undergo noncontrast CT and CT angiography imaging.
• • 4. Patients determined to have an intracranial large vessel occlusion (including the internal carotid artery, middle cerebral artery M1 segment, and M2 segment), and eligible for endovascular treatment.
• • Exclusion Criteria
• • 1) CT imaging with severe motion artifacts.